The 50% effective dose of hydromorphone and morphine for epidural analgesia in the hemorrhoidectomy: a double-blind, sequential dose-finding study.
ED50
Epidural analgesia
Hemorrhoidectomy
Hydromorphone
Morphine
Randomized controlled trial
Journal
BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
29
08
2023
accepted:
18
01
2024
medline:
31
1
2024
pubmed:
31
1
2024
entrez:
30
1
2024
Statut:
epublish
Résumé
Although previous studies have showed that epidural morphine can be used as a complement to local anesthetics for analgesia after postcesarean delivery under spinal anesthesia, there is little known about the analgesic dosage of epidural morphine and hydromorphone for hemorrhoidectomy. Therefore, we conducted this study to examine the potency ratio of hydromorphone to epidural morphine as well as effective analgesic dose for 50% patients (ED50) undergoing elective hemorrhoidectomy. 80 patients under elective hemorrhoidectomy with combined spinal and epidural anesthesia(CSEA) in department of anesthesia, Dongguan Tungwah hospital. To assess the ED50, patients were treated with epidural morphine or epidural hydromorphone randomly using a biased coin method-determined dose with a sequential allocation procedure. Following surgery, standardized multimodal analgesia was administered to all patients. A pain response score of ≤ 3 (on a scale of 0-10) was determined to be the effective dose after 24 h following CSEA. The ED50 in both groups were determined using the probit regression and isotonic regression method. We also measured pain intensity by patient interview using a 10 point verbal numeric rating scale prospectively at 6, 12 and 24 h after CSEA, and adverse effects were also noted. The ED50 was 0.350 mg (95% CI, 0.259-0.376 mg) in hydromorphone group and 1.129 mg (95% CI, 0.903-1.187 mg) in morphine group, respectively, estimated by isotonic regression method. Regression analysis with the probit, the ED50 of epidural hydromorphone was 0.366 mg (95% CI, 0.276-0.388 mg) and epidural morphine was 1.138 mg (95% CI, 0.910-1.201 mg). Exploratory findings showed that there was no difference between the most frequent dosages of epidural hydromorphone or epidural morphine in the occurrence of nausea, vomiting and pruritus. When administered with epidural opioids at ED50 doses or higher, 97.5% (39/40) of epidural morphine patients and 97.5% (39/40) epidural hydromorphone of patients were satisfied with their analgesia. Effective hemorrhoidectomy analgesia requires a 3:1 ratio of epidural morphine to epidural hydromorphone. Both drugs provide excellent patient satisfaction.
Sections du résumé
BACKGROUND
BACKGROUND
Although previous studies have showed that epidural morphine can be used as a complement to local anesthetics for analgesia after postcesarean delivery under spinal anesthesia, there is little known about the analgesic dosage of epidural morphine and hydromorphone for hemorrhoidectomy. Therefore, we conducted this study to examine the potency ratio of hydromorphone to epidural morphine as well as effective analgesic dose for 50% patients (ED50) undergoing elective hemorrhoidectomy.
METHODS
METHODS
80 patients under elective hemorrhoidectomy with combined spinal and epidural anesthesia(CSEA) in department of anesthesia, Dongguan Tungwah hospital. To assess the ED50, patients were treated with epidural morphine or epidural hydromorphone randomly using a biased coin method-determined dose with a sequential allocation procedure. Following surgery, standardized multimodal analgesia was administered to all patients. A pain response score of ≤ 3 (on a scale of 0-10) was determined to be the effective dose after 24 h following CSEA. The ED50 in both groups were determined using the probit regression and isotonic regression method. We also measured pain intensity by patient interview using a 10 point verbal numeric rating scale prospectively at 6, 12 and 24 h after CSEA, and adverse effects were also noted.
RESULTS
RESULTS
The ED50 was 0.350 mg (95% CI, 0.259-0.376 mg) in hydromorphone group and 1.129 mg (95% CI, 0.903-1.187 mg) in morphine group, respectively, estimated by isotonic regression method. Regression analysis with the probit, the ED50 of epidural hydromorphone was 0.366 mg (95% CI, 0.276-0.388 mg) and epidural morphine was 1.138 mg (95% CI, 0.910-1.201 mg). Exploratory findings showed that there was no difference between the most frequent dosages of epidural hydromorphone or epidural morphine in the occurrence of nausea, vomiting and pruritus. When administered with epidural opioids at ED50 doses or higher, 97.5% (39/40) of epidural morphine patients and 97.5% (39/40) epidural hydromorphone of patients were satisfied with their analgesia.
CONCLUSION
CONCLUSIONS
Effective hemorrhoidectomy analgesia requires a 3:1 ratio of epidural morphine to epidural hydromorphone. Both drugs provide excellent patient satisfaction.
Identifiants
pubmed: 38291353
doi: 10.1186/s12871-024-02420-0
pii: 10.1186/s12871-024-02420-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
41Informations de copyright
© 2024. The Author(s).
Références
Huang Y-J, Chen C-Y, Chen R-J, Kang Y-N, Wei P-L. Topical diltiazem ointment in post-hemorrhoidectomy pain relief: a meta-analysis of randomized controlled trials. Asian J Surg. 2018;41:431–7.
doi: 10.1016/j.asjsur.2017.06.002
pubmed: 28698000
Nadri S, Mahmoudvand H, Rokrok S, Tarrahi MJ. Comparison of two methods: spinal anesthesia and Ischiorectal Block on Post Hemorrhoidectomy Pain and Hospital Stay: a Randomized Control Trial. J Invest Surg. 2018;31:420–4.
doi: 10.1080/08941939.2017.1349221
pubmed: 29172862
Okuş A. Local Pain-reducing methods after hemorrhoidectomy. World J Surg. 2013;37:2007–8.
doi: 10.1007/s00268-013-1983-z
pubmed: 23494084
pmcid: 3715688
Lohsiriwat V, Jitmungngan R. Strategies to Reduce Post-hemorrhoidectomy Pain: a systematic review. Med (Mex). 2022;58:418.
Santa Cruz Mercado LA, Liu R, Bharadwaj KM, Johnson JJ, Gutierrez R, Das P, et al. Association of Intraoperative Opioid Administration with Postoperative Pain and Opioid Use. JAMA Surg. 2023;158:854.
doi: 10.1001/jamasurg.2023.2009
pubmed: 37314800
pmcid: 10267849
Rosero EB, Joshi GP. Preemptive, preventive, Multimodal Analgesia: what do they really Mean? Plast Reconstr Surg. 2014;134:85S–93S.
doi: 10.1097/PRS.0000000000000671
pubmed: 25255012
Sviggum HP, Arendt KW, Jacob AK, Niesen AD, Johnson RL, Schroeder DR, et al. Intrathecal Hydromorphone and Morphine for Postcesarean Delivery Analgesia: determination of the ED90 using a sequential allocation biased-Coin Method. Anesth Analg. 2016;123:690–7.
doi: 10.1213/ANE.0000000000001229
pubmed: 26974022
Sharpe EE, Molitor RJ, Arendt KW, Torbenson VE, Olsen DA, Johnson RL, et al. Intrathecal Morphine versus Intrathecal Hydromorphone for Analgesia after Cesarean Delivery. Anesthesiology. 2020;132:1382–91.
doi: 10.1097/ALN.0000000000003283
pubmed: 32251031
Lynde GC. Determination of ED50 of hydromorphone for postoperative analgesia following cesarean delivery. Int J Obstet Anesth. 2016;28:17–21.
doi: 10.1016/j.ijoa.2016.07.005
pubmed: 27641091
Beatty NC, Arendt KW, Niesen AD, Wittwer ED, Jacob AK. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine. J Clin Anesth. 2013;25:379–83.
doi: 10.1016/j.jclinane.2013.01.014
pubmed: 23965210
Hoogma DF, Brullot L, Coppens S. Get your 7-point golden medal for pain management in video-assisted thoracoscopic surgery. Curr Opin Anaesthesiol. 2024;37:64–8.
doi: 10.1097/ACO.0000000000001325
Sifaki F, Vogiatzaki T, Mantzoros I, Koraki E, Christidis P, Pramateftakis M-G, et al. The effectiveness of Ultrasound-Guided, continuous, bilateral Erector Spinae Plane Block in Perioperative Pain Management of patients undergoing colorectal surgery: a Randomized, controlled, double blind, prospective trial. J Clin Med. 2023;12:7465.
doi: 10.3390/jcm12237465
pmcid: 10707092
Bielewicz J, Daniluk B, Kamieniak P. VAS and NRS, same or different? Are visual Analog Scale values and Numerical Rating Scale equally viable tools for assessing patients after Microdiscectomy? Pain Res Manag. 2022;2022:1–6.
doi: 10.1155/2022/5337483
Sharawi N, Tan HS, Taylor C, Fuller ME, Landreth RA, Diomede OI, et al. editors. 90 of Intrathecal Chloroprocaine With Fentanyl for Prophylactic Cervical Cerclage: A Sequential Allocation Biased-Coin Design. Anesth Analg. 2022;134:834–42.
Song Y, Du W, Tao Y, Li Q, Shen F, Xu Z, et al. Optimum programmed intermittent epidural bolus interval time between 8 mL boluses of Ropivacaine 0.1% with sufentanil 0.3 µg/mL with dural puncture epidural technique for labor analgesia: a biased-coin up-and-down sequential allocation trial. J Clin Anesth. 2022;79:110698.
doi: 10.1016/j.jclinane.2022.110698
pubmed: 35255351
Maeda A, Villela-Franyutti D, Lumbreras-Marquez MI, Murthy A, Fields KG, Justice S, et al. Labor analgesia initiation with Dural puncture Epidural Versus Conventional Epidural techniques: a Randomized biased-Coin Sequential Allocation Trial to determine the effective dose for 90% of patients of Bupivacaine. Anesth Analg. 2023. https://doi.org/10.1213/ANE.0000000000006691 .
doi: 10.1213/ANE.0000000000006691
pubmed: 37824436
Ely EW, Truman B, Shintani A, Thomason JWW, Wheeler AP, Gordon S, et al. Monitoring sedation Status Over Time in ICU patients: reliability and validity of the Richmond agitation-sedation scale (RASS). JAMA. 2003;289:2983.
doi: 10.1001/jama.289.22.2983
pubmed: 12799407
Qu L, Liu M, Ouyang R, Li T, Long D, Jiang Y, et al. Determination of the 95% effective dose of remimazolam tosylate in anesthesia induction inhibits endotracheal intubation response in senile patients. Front Pharmacol. 2023;14:1136003.
doi: 10.3389/fphar.2023.1136003
pubmed: 37324498
pmcid: 10266225
Ran X, Zhou S, Cao K, He P. Optimization of programmed intermittent epidural bolus volume for different concentrations of ropivacaine in labor analgesia: a biased coin up-and-down sequential allocation trial. BMC Pregnancy Childbirth. 2022;22:590.
doi: 10.1186/s12884-022-04912-8
pubmed: 35879705
pmcid: 9310404
Tang Y, Yang M, Fu F, Huang X, Feng Y, Chen X. Comparison of the ED50 of intrathecal hyperbaric ropivacaine co-administered with or without intrathecal dexmedetomidine for cesarean section: a prospective, double-blinded, randomized dose-response trial using up-down sequential allocation method. J Clin Anesth. 2020;62:109725.
doi: 10.1016/j.jclinane.2020.109725
pubmed: 32036258
Liu M, Sun Y, Zhou L, Feng K, Wang T, Feng X. The median effective dose and Bispectral Index of Remimazolam Tosilate for Anesthesia induction in Elderly patients: an Up-and-down sequential allocation trial. Clin Interv Aging. 2022;Volume 17:837–43.
doi: 10.2147/CIA.S364222
Pace NL, Stylianou MP, Warltier DC. Advances in and limitations of Up-and-down methodology. Anesthesiology. 2007;107:144–52.
doi: 10.1097/01.anes.0000267514.42592.2a
pubmed: 17585226
Stylianou M, Flournoy N. Dose finding using the biased Coin Up-and‐Down Design and Isotonic regression. Biometrics. 2002;58:171–7.
doi: 10.1111/j.0006-341X.2002.00171.x
pubmed: 11890313
Stylianou M, Proschan M, Flournoy N. Estimating the probability of toxicity at the target dose following an up-and‐down design. Stat Med. 2003;22:535–43.
doi: 10.1002/sim.1351
pubmed: 12590412
Shen T, Zheng J, Xu Z, Zhang C, Shen Y, Xu T. The 90% effective dose of Sufentanil for Epidural Analgesia in the Early First Stage of Labor: a Double-blind, sequential dose-finding study. Clin Ther. 2021;43:1191–200.
doi: 10.1016/j.clinthera.2021.05.002
pubmed: 34108078
Grosset AB, Roberts MS, Woodson ME, Shi M, Swanton RE, Reder RF, et al. Comparative efficacy of oral extended-release hydromorphone and Immediate-Release Hydromorphone in patients with persistent moderate to severe Pain: two randomized controlled trials. J Pain Symptom Manage. 2005;29:584–94.
doi: 10.1016/j.jpainsymman.2004.10.008
pubmed: 15963867
Bao YJ, Hou W, Kong XY, Yang L, Xia J, Hua BJ, et al. Hydromorphone for cancer pain. Cochrane Database Syst Rev. 2016. https://doi.org/10.1002/14651858.CD011108.pub2 .
doi: 10.1002/14651858.CD011108.pub2
pubmed: 27727452
pmcid: 6457981
Yang M, Wang L, Chen H, Tang Y, Chen X. Postoperative analgesic effects of different doses of Epidural Hydromorphone Coadministered with Ropivacaine after Cesarean Section: a Randomized Controlled Trial. Pain Res Manag. 2019;2019:1–5.
Puhto T, Kokki M, Hakomäki H, Spalding M, Gunnar T, Alahuhta S, et al. Single dose epidural hydromorphone in labour pain: maternal pharmacokinetics and neonatal exposure. Eur J Clin Pharmacol. 2020;76:969–77.
doi: 10.1007/s00228-020-02880-6
pubmed: 32363420
pmcid: 7306027
Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Clin Ther. 2006;28:86–98.
doi: 10.1016/j.clinthera.2006.01.010
pubmed: 16490582
Rodrigues S, Shin D, Conway M, Smulski S, Trenker E, Shanthanna H, et al. Hydromorphone versus morphine: a historical cohort study to evaluate the quality of postoperative analgesia. Can J Anesth Can Anesth. 2021;68:226–34.
doi: 10.1007/s12630-020-01849-4
Spénard S, Gélinas C, Trottier D, Tremblay-Racine E, Kleiber F. Morphine or hydromorphone: which should be preferred? A systematic review. Arch Dis Child. 2021;106:1002–9.
doi: 10.1136/archdischild-2020-319059
pubmed: 33461958
Meissner K, Dahan A, Olofsen E, Göpfert C, Blood J, Wieditz J, et al. Morphine and Hydromorphone effects, Side effects, and variability: a crossover study in human volunteers. Anesthesiology. 2023;139:16–34.
doi: 10.1097/ALN.0000000000004567
pubmed: 37014986
Nguyen MN, Zimmerman LH, Meloche K, Dolman HS, Baylor AE, Fuleihan S, et al. Hydromorphone vs fentanyl for epidural analgesia and anesthesia. Am J Surg. 2016;211:565–70.
doi: 10.1016/j.amjsurg.2015.12.003
Tang J, Zheng Z, Ran Q, Zhao F, Wang Y, Hu F, et al. Epidural esketamine and morphine for postoperative analgesia after caesarean delivery: a pilot study. Front Surg. 2023;9:988392.
doi: 10.3389/fsurg.2022.988392
pubmed: 36684305
pmcid: 9852529
Bian Y, Zhou S, Hou H, Xu T, Huang Y. The optimal dose of oral midazolam with or without intranasal S-ketamine for premedication in children: a randomised, double blinded, sequential dose-finding trial. Transl Pediatr. 2021;10:2941–51.
doi: 10.21037/tp-21-247
pubmed: 34976760
pmcid: 8649604
Zhang J, Chen Y, Li S, Liu H, Tu S. The 90% effective dose of intranasal dexmedetomidine for procedural sedation in children with congenital heart disease before and after surgery: a biased-coin design up‐and‐down sequential allocation trial. Acta Anaesthesiol Scand. 2021;65:188–94.
doi: 10.1111/aas.13693
pubmed: 32888187